Raymond James Financial is a US-listed company in the investment banking & brokerage industry. Its financial year ends in September.
Loading chart…
Third-party market data · may be delayed
~$190
Valuation models combined (4)
Base case. Range ~$150–$240. Weighted average of 4 models (forward price-to-earnings vs peers, residual income, justified price-to-book, dividend discount (two-stage)), the forward price-to-earnings vs peers counting double.
Modestly undervalued
The price is inside our value range, 16% below our base value.
Price used: $162.30, November 2, 2026
Raymond James Financial valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to June 2026 was $17.0bn, up 8.0% on a year earlier, faster than 5.3% a quarter earlier. The diluted share count is down 3.9% on a year earlier, which lifts each remaining share. Our valuation models combined value is $182 a share, against a share price of $156.
Source: 10-Q filed August 5, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Raymond James Financial's trailing-twelve-month revenue grew 8.0% year on year, with a free-cash-flow margin of 8.5%. Where it stands out: change in share count of -3.9% ranks 2 of 35 investment banking & brokerage companies we cover.
Current signal Free cash flow diverging from earnings: TTM free cash flow fell 26.2% while net income grew 8.1%: a 34pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
We value Raymond James Financial as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$240 ~$190–$370 | Primary model, counts double |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$160 ~$120–$230 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$150 ~$130–$180 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$6.5 ~$68–$290 | Left out: out of range vs price (0.04x) |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | ~$160 ~$140–$200 | Included |
| Combined value Weighted average of the models that apply: the primary model (forward price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$190 ~$150–$240 | 4 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Raymond James Financial with brokers, investment banks and exchanges in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Strong moat
How hard Raymond James Financial's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Net income has been a median 2.2% of total assets over 10 years.
Net margin has been a median 13.1%; its worst year was 9.8%.
The diluted share count fell 8.5% over five years; stock-based pay has been a median 1.5% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (88 before it).
Next results: January 27, 2027, after the close. Analysts expect revenue of $4.2bn and EPS of $3.36 (range $3.21 to $3.49) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $14.31 | +15% | $17.7bn | +12% |
| Next | $16.22 | +13% | $18.9bn | +7% |
Next year's EPS estimate has moved +2.7% in 90 days, across 10 analysts.
The consensus EPS forecast for the current fiscal year is +0.9% on 90 days ago. In the last 30 days, 5 analysts raised Raymond James Financial's forecast and 2 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $14.18 | $15.79 |
| 60 days ago | $14.18 | $15.79 |
| 30 days ago | $14.20 | $15.99 |
| 7 days ago | $14.27 | $16.06 |
| Now | $14.31 | $16.22 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $3.27 | $3.59 | +9.8% |
| Jun 2026 | $2.91 | $3.14 | +7.8% |
| Mar 2026 | $2.76 | $2.83 | +2.5% |
| Dec 2025 | $2.83 | $2.86 | +0.9% |
Adjusted EPS as companies report it, against the average analyst estimate.
Last 12 months +3.7%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $15.7bn | $17.0bn | +8.0% |
| Net margin | 13.6% | 13.6% | +0.1% |
| P/E multiple | 15.3x | 14.1x | −7.8% |
| Share count | 208m | 200m | +4.0% |
Biggest factor: p/e multiple.
Last 3 years +67.1%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $12.5bn | $17.0bn | +36.2% |
| Net margin | 14.0% | 13.6% | −2.9% |
| P/E multiple | 12.2x | 14.1x | +15.8% |
| Share count | 219m | 200m | +9.2% |
Biggest factor: revenue.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| RJF | +60% | +8% | +6% | +41% | +5% | +3% |
| Industry peers (median) | +26% | −20% | +19% | +45% | +10% | −16% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| RJF | 67% | 58% | 42% | 67% | 58% | 55% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| RJF | −10% | −26% | −29% | −18% | −28% | −19% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 3, 2015: 46% from February 19, 2020 to March 23, 2020. Getting back needed a 84% gain, reached on January 6, 2021, 289 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| October 28, 2026 | +2.0% | 0.0% | — | — |
| July 22, 2026 | −1.1% | −1.3% | +3.7% | +2.6% |
| April 22, 2026 | −0.7% | +0.6% | +0.7% | −2.7% |
| January 28, 2026 | −0.8% | −0.2% | +0.5% | −9.4% |
| October 22, 2025 | −0.4% | +0.1% | −4.5% | −8.7% |
| July 23, 2025 | +3.9% | +0.9% | +5.5% | +0.9% |
| April 23, 2025 | +1.8% | +3.7% | +1.7% | +8.7% |
| January 29, 2025 | −0.5% | +0.1% | −3.4% | −9.8% |
| October 23, 2024 | +8.2% | −0.7% | +9.5% | +20.3% |
| July 24, 2024 | +5.5% | −2.8% | +3.7% | +3.9% |
| April 24, 2024 | −4.1% | −0.4% | −3.6% | −2.9% |
| January 24, 2024 | +0.4% | +0.7% | −2.9% | +4.5% |
How Raymond James Financial’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
Not offered: no liquid put with an effective price at or below fair value.
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.
For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.
Not offered: the shares trade below our fair value: a collar caps upside the model expects.
For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved October 20, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q4 | $13B |
| FY24 Q1 | $13.5B |
| FY24 Q2 | $14B |
| FY24 Q3 | $14.4B |
| FY24 Q4 | $14.9B |
| FY25 Q1 | $15.4B |
| FY25 Q2 | $15.6B |
| FY25 Q3 | $15.7B |
| FY25 Q4 | $15.9B |
| FY26 Q1 | $16.1B |
| FY26 Q2 | $16.5B |
| FY26 Q3 | $17B |
Source: SEC EDGAR filings. Retrieved October 20, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q4 | 14.9% |
| FY24 Q1 | 17.1% |
| FY24 Q2 | 16.7% |
| FY24 Q3 | 15.7% |
| FY24 Q4 | 14.9% |
| FY25 Q1 | 14.5% |
| FY25 Q2 | 12.0% |
| FY25 Q3 | 8.9% |
| FY25 Q4 | 6.6% |
| FY26 Q1 | 4.0% |
| FY26 Q2 | 5.3% |
| FY26 Q3 | 8.0% |
Source: SEC EDGAR filings. Retrieved October 20, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY23 Q4 | -28.4% |
| FY24 Q1 | -0.2% |
| FY24 Q2 | 7.0% |
| FY24 Q3 | 13.0% |
| FY24 Q4 | 13.1% |
| FY25 Q1 | 14.5% |
| FY25 Q2 | 12.6% |
| FY25 Q3 | 12.4% |
| FY25 Q4 | 14.1% |
| FY26 Q1 | 8.7% |
| FY26 Q2 | 14.5% |
| FY26 Q3 | 8.5% |
| Fiscal year | 2009 Sept 2009 | 2010 Sept 2010 | 2011 Sept 2011 | 2012 Sept 2012 | 2013 Sept 2013 | 2014 Sept 2014 | 2015 Sept 2015 | 2016 Sept 2016 | 2017 Sept 2017 | 2018 Sept 2018 | 2019 Sept 2019 | 2020 Sept 2020 | 2021 Sept 2021 | 2022 Sept 2022 | 2023 Sept 2023 | 2024 Sept 2024 | 2025 Sept 2025 | LTM Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 2.6 | 3.0 | 3.4 | 3.9 | 4.6 | 5.0 | 5.3 | 5.5 | 6.5 | 7.5 | 8.0 | 8.2 | 9.9 | 11.3 | 13.0 | 14.9 | 15.9 | 17.0 |
| Net income | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.9 | 1.0 | 0.8 | 1.4 | 1.5 | 1.7 | 2.1 | 2.1 | 2.3 |
| Diluted EPS | $0.83 | $1.22 | $1.46 | $1.47 | $1.72 | $2.21 | $2.29 | $2.43 | $2.89 | $3.83 | $4.78 | $3.88 | $6.63 | $6.98 | $7.97 | $9.70 | $10.30 | $11.52 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | −18.8% | +14.5% | +14.1% | +14.6% | +17.9% | +8.0% | +6.9% | +4.0% | +18.2% | +14.6% | +7.3% | +1.8% | +21.3% | +14.1% | +14.9% | +14.9% | +6.6% | +8.0% |
| Net income | −35.0% | +49.4% | +21.9% | +6.3% | +24.1% | +30.8% | +4.6% | +5.4% | +20.1% | +34.7% | +20.7% | −20.9% | +71.5% | +7.6% | +15.2% | +18.9% | +3.2% | +8.1% |
| Diluted EPS | −35.2% | +46.4% | +19.7% | +0.5% | +17.3% | +28.7% | +3.3% | +6.4% | +18.6% | +32.8% | +24.7% | −18.8% | +70.9% | +5.3% | +14.2% | +21.7% | +6.2% | +12.5% |
| Margins | ||||||||||||||||||
| Net margin | 5.9% | 7.7% | 8.2% | 7.6% | 8.0% | 9.7% | 9.5% | 9.6% | 9.7% | 11.5% | 12.9% | 10.0% | 14.2% | 13.3% | 13.4% | 13.9% | 13.4% | 13.6% |
| Free-cash-flow margin | 13.0% | −35.0% | 44.7% | 8.0% | 12.8% | 9.0% | 15.5% | −12.6% | −4.8% | 10.0% | 5.5% | 48.3% | 66.3% | −0.2% | −28.4% | 13.1% | 14.1% | 8.5% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 0.4 | −1.0 | 1.6 | 0.4 | 0.7 | 0.5 | 0.9 | −0.6 | −0.1 | 0.9 | 0.6 | 4.1 | 6.6 | 0.1 | −3.5 | 2.2 | 2.4 | 1.6 |
| Capital spending | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Free cash flow | 0.3 | −1.0 | 1.5 | 0.3 | 0.6 | 0.4 | 0.8 | −0.7 | −0.3 | 0.8 | 0.4 | 3.9 | 6.6 | −0.0 | −3.7 | 2.0 | 2.2 | 1.4 |
| Stock-based pay | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 |
| Free cash flow after stock pay | 0.3 | −1.1 | 1.5 | 0.3 | 0.5 | 0.4 | 0.8 | −0.8 | −0.4 | 0.7 | 0.3 | 3.8 | 6.4 | −0.2 | −3.9 | 1.7 | 2.0 | 1.2 |
| Balance sheet | ||||||||||||||||||
| Cash | 2.3 | 2.9 | 2.4 | 2.0 | 2.6 | 2.2 | 2.6 | 1.7 | 3.7 | 3.5 | 4.0 | 5.4 | 7.2 | 6.2 | 9.3 | 11.0 | 11.4 | 10.0 |
| Total debt | 0.0 | 0.4 | 0.6 | 0.0 | 1.2 | 1.2 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 1.0 |
| Net debt (negative = net cash) | −2.3 | −2.6 | −1.8 | −2.0 | −1.4 | −1.0 | −1.4 | −1.7 | −3.7 | −3.5 | −4.0 | −5.4 | −7.2 | −6.2 | −9.3 | −11.0 | −10.7 | −9.0 |
| Diluted shares | 176m | 179m | 184m | 198m | 211m | 215m | 219m | 217m | 220m | 223m | 216m | 210m | 211m | 215m | 217m | 212m | 207m | 200m |
| Returned to shareholders | ||||||||||||||||||
| Dividends | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 |
| Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.1 | 0.8 | 0.3 | 0.1 | — | — | — | — | — |
| Total returned | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 | 1.0 | 0.5 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 |
| Quarter | 2024 Q4 Sept 2024 | 2025 Q1 Dec 2024 | 2025 Q2 Mar 2025 | 2025 Q3 Jun 2025 | 2025 Q4 Sept 2025 | 2026 Q1 Dec 2025 | 2026 Q2 Mar 2026 | 2026 Q3 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 4,003 | 4,035 | 3,845 | 3,842 | 4,190 | 4,176 | 4,262 | 4,362 |
| Net income | 602 | 600 | 495 | 436 | 604 | 563 | 544 | 595 |
| Diluted EPS | $2.85 | $2.86 | $2.36 | $2.12 | $2.95 | $2.79 | $2.72 | $3.01 |
| Growth (year on year) | ||||||||
| Revenue | +13.9% | +14.6% | +5.7% | +2.1% | +4.7% | +3.5% | +10.8% | +13.5% |
| Net income | +38.7% | +20.5% | +4.0% | −11.4% | +0.3% | −6.2% | +9.9% | +36.5% |
| Diluted EPS | +41.1% | +23.3% | +6.3% | −8.2% | +3.5% | −2.4% | +15.3% | +42.0% |
| Margins | ||||||||
| Net margin | 15.0% | 14.9% | 12.9% | 11.3% | 14.4% | 13.5% | 12.8% | 13.6% |
| Free-cash-flow margin | 11.5% | 19.6% | 1.8% | 16.5% | 17.9% | −1.3% | 24.7% | −7.1% |
| Cash flow | ||||||||
| Cash from operations | 510 | 830 | 117 | 691 | 796 | −10 | 1,099 | −246 |
| Capital spending | 50 | 41 | 46 | 57 | 44 | 46 | 45 | 62 |
| Free cash flow | 460 | 789 | 71 | 634 | 752 | −56 | 1,054 | −308 |
| Stock-based pay | 53 | 93 | 54 | 52 | 55 | 79 | 54 | 50 |
| Free cash flow after stock pay | 407 | 696 | 17 | 582 | 697 | −135 | 1,000 | −358 |
| Last 12 months unless stated | RJF | LPLA | ETOR | JEF | SCHW | IBKR | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $17.0bn | $20.4bn | $13.8bn | $12.2bn | $26.0bn | $6.9bn | $2.0bn |
| Revenue growth, last 12 months | 8.0% | 31.0% | 9.5% | 13.5% | 20.3% | 21.3% | 20.7% |
| Revenue growth, 3-year average | 10.8% | 27.9% | — | 18.7% | 7.8% | 12.8% | 16.2% |
| Revenue growth, latest quarter | 13.5% | 17.4% | — | 11.1% | 20.9% | 28.1% | 17.4% |
| Gross margin | — | — | 1.8% | 98.7% | — | — | 3.6% |
| Net margin | 13.6% | 6.8% | 1.6% | 7.3% | 38.8% | 16.4% | 5.8% |
| Cash from operations / revenue | 9.6% | 8.7% | 2.3% | 36.3% | 43.9% | 231.9% | 7.7% |
| Free-cash-flow margin | 8.5% | 4.9% | 2.3% | 34.5% | 41.5% | 231.0% | 5.2% |
| Free-cash-flow margin, 3-year average | 11.3% | −2.2% | — | −1.5% | 56.3% | 212.3% | 16.8% |
| Stock pay / revenue | 1.4% | 0.4% | 0.1% | 3.1% | 1.3% | 1.8% | 4.7% |
| Change in share count | −3.9% | 2.8% | 11.5% | 0.0% | −3.2% | 4.7% | 1.2% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 8.0% | 20.8% | 30 of 40 |
| Change in growth rate Growth | +2.8pp | -0.3pp | 14 of 40 |
| Net margin Profitability | 13.6% | 6.0% | 15 of 40 |
| Stock pay as % of revenue Cash generation | 1.4% | 4.8% | 8 of 36 |
| Change in share count Balance sheet | -3.9% | 1.2% | 2 of 35 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Asset Management and Related Administrative Fee Revenue | $7.1B | 45.3% | ▲ 14.2% |
| Brokerage Revenue Securities Commissions | $1.8B | 11.4% | ▲ 7.5% |
| Account and Service Fee Revenue | $1.3B | 8.1% | ▼ 4.0% |
| Investment Banking Revenue | $1.1B | 6.8% | ▲ 24.6% |
| Equities ET Fs and Fixed Income Products | $650M | 4.2% | ▲ 16.7% |
| Investment Banking Revenue Mergers and Acquisition and Advisory | $623M | 4.0% | ▲ 19.6% |
| Brokerage Revenue Securities Commissions Mutual and Other Fund Products | $614M | 3.9% | ▲ 6.8% |
| Mutual Fund and Other | $530M | 3.4% | ▲ 12.8% |
| Brokerage Revenue Securities Commissions Insurance and Annuity Products | $511M | 3.3% | ▼ 1.5% |
| Account and Service Fee Revenue RJBDP Fees | $486M | 3.1% | ▼ 19.9% |
| Investment Banking Revenue Debt Underwriting | $261M | 1.7% | ▲ 55.4% |
| Account and Service Fee Revenue Client Account and Other Fees | $246M | 1.6% | ▲ 3.8% |
| Other Revenue | $205M | 1.3% | ▲ 13.9% |
| Investment Banking Revenue Equity Underwriting | $185M | 1.2% | ▲ 9.5% |
| Affordable Housing Investments Business | $140M | 0.9% | ▲ 18.6% |
From Raymond James Financial's 10-K filed November 25, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $2.2B | 14.3M | 9.5% | ▲ 1.6% |
| Vanguard Capital Management LLC | $1.7B | 11.2M | 7.4% | ▼ 1.1% |
| Wellington Management Group LLP | $1.4B | 9.4M | 6.2% | ▼ 2.6% |
| Primecap Management Co | $1.4B | 9.2M | 6.1% | ▼ 1.1% |
| Vanguard Portfolio Management LLC | $1.4B | 8.9M | 5.9% | ▼ 1.8% |
| State Street Corp | $1.2B | 7.9M | 5.2% | ▲ 0.4% |
| Geode Capital Management, LLC | $704M | 4.6M | 3.1% | ▲ 0.2% |
| FMR LLC | $670M | 4.4M | 2.9% | ▼ 24.7% |
| Harris Associates L P | $562M | 3.7M | 2.4% | ▲ 7.8% |
| T. Rowe Price Investment Management, Inc. | $427M | 2.8M | 1.8% | ▼ 18.1% |
| Jpmorgan Chase & Co | $404M | 2.7M | 1.8% | ▼ 39.3% |
| Dimensional Fund Advisors LP | $372M | 2.4M | 1.6% | ▲ 2.1% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Raymond James Financial's complete shareholder register. Values are as reported by the filers ; 7 inconsistently scaled filing rows were excluded.
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Allaire Bella Loykhter Chief Admin Officer | August 28, 2026 | Sell | 7,500 | $177.60 | $1.3M |
| Elwyn Tashtego S President, PCG | July 28, 2026 | Sell | 10,000 | $176.06 | $1.8M |
| Raney Steven M Executive Chair RJBank | July 27, 2026 | Sell | 5,770 | $172.97 | $998,037 |
| Allaire Bella Loykhter Chief Admin Officer | March 19, 2026 | Sell | 29,551 | $142.34 | $4.2M |
| Santelli Jonathan N EVP, General Counsel | February 4, 2026 | Sell | 4,500 | $170.46 | $767,070 |
| Reilly Paul C Executive Chair | December 15, 2025 | Sell | 20,270 | $164.22 | $3.3M |
| Reilly Paul C Executive Chair | December 15, 2025 | Sell | 53,660 | $163.24 | $8.8M |
| Reilly Paul C Executive Chair | December 15, 2025 | Sell | 56,757 | $162.69 | $9.2M |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
No trades in Raymond James Financial disclosed in the last 12 months; 5 earlier trades on record.
Next expected around January 27, 2027 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
